Article Versions Notes

Dziawer Ł, Majkowska-Pilip A, Gaweł D, Godlewska M, Pruszyński M, Jastrzębski J, Wąs B, Bilewicz A. Trastuzumab-Modified Gold Nanoparticles Labeled with ²¹¹At as a Prospective Tool for Local Treatment of HER2-Positive Breast Cancer. Nanomaterials. 2019; 9(4):632. https://doi.org/10.3390/nano9040632

Dziawer, Łucja, Agnieszka Majkowska-Pilip, Damian Gaweł, Marlena Godlewska, Marek Pruszyński, Jerzy Jastrzębski, Bogdan Wąs, and Aleksander Bilewicz. 2019. "Trastuzumab-Modified Gold Nanoparticles Labeled with ²¹¹At as a Prospective Tool for Local Treatment of HER2-Positive Breast Cancer" Nanomaterials 9, no. 4: 632. https://doi.org/10.3390/nano9040632

Dziawer, Ł., Majkowska-Pilip, A., Gaweł, D., Godlewska, M., Pruszyński, M., Jastrzębski, J., Wąs, B., & Bilewicz, A. (2019). Trastuzumab-Modified Gold Nanoparticles Labeled with ²¹¹At as a Prospective Tool for Local Treatment of HER2-Positive Breast Cancer. Nanomaterials, 9(4), 632. https://doi.org/10.3390/nano9040632